Vir Biotechnology Inc (VIR)
9.91
-0.32
(-3.08%)
USD |
NASDAQ |
May 07, 13:26
Vir Biotechnology Free Cash Flow (Quarterly): -109.46M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -109.46M |
| September 30, 2023 | -159.54M |
| June 30, 2023 | -398.70M |
| March 31, 2023 | -132.65M |
| December 31, 2022 | 22.55M |
| September 30, 2022 | 98.91M |
| June 30, 2022 | 939.54M |
| March 31, 2022 | 534.25M |
| December 31, 2021 | -5.372M |
| September 30, 2021 | -111.82M |
| Date | Value |
|---|---|
| June 30, 2021 | 137.98M |
| March 31, 2021 | -90.20M |
| December 31, 2020 | -84.48M |
| September 30, 2020 | -51.32M |
| June 30, 2020 | -11.98M |
| March 31, 2020 | -49.71M |
| December 31, 2019 | -40.44M |
| September 30, 2019 | -38.21M |
| June 30, 2019 | -26.96M |
| March 31, 2019 | -32.96M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-398.70M
Minimum
Jun 2023
939.54M
Maximum
Jun 2022
22.23M
Average
-40.44M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 118.50M |
| Vistagen Therapeutics Inc | -4.568M |
| Immuneering Corp | -11.95M |
| SeaStar Medical Holding Corp | -4.485M |
| NovaBay Pharmaceuticals Inc | -0.316M |